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The virion glycoproteins Gn and Gc of Bunyamwera orthobunyavirus (family Bunyaviridae) are
encoded by the M RNA genome segment and have roles in both viral attachment and membrane
fusion. To investigate further the structure and function of the Gc protein in viral replication, we
generated 12 mutants that contain truncations from the N terminus. The effects of these deletions
were analysed with regard to Golgi targeting, low pH-dependent membrane fusion, infectious
virus-like particle (VLP) formation and virus infectivity. Our results show that the N-terminal half
(453 residues) of the Gc ectodomain (909 residues in total) is dispensable for Golgi trafficking
and cell fusion. However, deletions in this region resulted in a significant reduction in VLP
formation. Four mutant viruses that contained N-terminal deletions in their Gc proteins were
rescued, and found to be attenuated to different degrees in BHK-21 cells. Taken together, our
data indicate that the N-terminal half of the Gc ectodomain is dispensable for replication in cell
culture, whereas the C-terminal half is required to mediate cell fusion. A model for the domain
structure of the Gc ectodomain is proposed.
INTRODUCTION
Viruses in the family Bunyaviridae (known as bunya-
viruses) are mainly arthropod-transmitted and are clas-
sified into five genera: Orthobunyavirus, Hantavirus,
Nairovirus, Phlebovirus and Tospovirus. Several bunya-
viruses are important human pathogens causing emerging
zoonotic infections, such as La Crosse (LACV), Hantaan
(HTNV), Sin Nombre (SNV), Rift Valley fever (RVFV) and
Crimean–Congo hemorrhagic fever (CCHFV) viruses. The
characteristic features of bunyaviruses include similarity in
virion morphology, possession of a tripartite, single-
stranded RNA genome of negative- or ambisense polarity,
cytoplasmic site of virus replication, and assembly and
budding occurring at membranes of the Golgi complex
(Elliott et al., 2000; Nichol et al., 2005). Bunyamwera virus
(BUNV) is the prototype of both the family Bunyaviridae
and the genus Orthobunyavirus.
Orthobunyaviruses encode two glycoproteins called Gn
and Gc that form spikes on the virus particle and are
involved in viral attachment and cell fusion (Schmaljohn &
Hooper, 2001). They are encoded by the medium (M)
RNA genome segment as a precursor protein (Gn–NSm–
Gc), which is cleaved co-translationally to yield the two
mature glycoproteins and a non-structural protein termed
NSm (Elliott, 1996). Both Gn and Gc are type I integral
transmembrane (TM) proteins and are modified by N-
linked glycosylation (Nichol et al., 2005; Schmaljohn &
Hooper, 2001; Shi et al., 2005). The BUNV Gn protein
consists of 302 residues with a rather long predicted
cytoplasmic tail (CT) of 78 residues, whilst its larger
counterpart Gc encompasses 957 residues with a shorter
CT of 25 residues (Elliott, 1990; Lees et al., 1986). The two
proteins form a heterodimer and Gn plays a chaperone-like
role to promote Gc folding and Golgi targeting (Shi et al.,
2004, 2005).
It is generally accepted that both glycoproteins are required
for virus entry, but little is known about the involvement of
the individual glycoproteins in the early events of virus
infection. Studies on LACV implicated Gc as the viral
attachment protein for both insect and mammalian cells
(Hacker et al., 1995; Kingsford et al., 1983; Sundin et al.,
1987), although other data suggest Gc as the attachment
protein for mammalian cells and Gn for mosquito cells
(Ludwig et al., 1991). However, as two non-temperature-
sensitive (ts) revertants (R1 and R2) of a ts mutant of
Maguari virus (MAGV, also an orthobunyavirus) contain
considerable deletions in the N terminus of Gc (R1 has 239
residues deleted and R2 has 431 aa missing; Elliott et al.,
1984; Murphy & Pringle, 1987; Pollitt et al., 2006), the N-
terminal region of the larger glycoprotein is not required
for infection of, or replication in, cultured mammalian
cells.
The glycoproteins of most enveloped viruses are also
fusogenic in order to deliver the viral genome into the
cytoplasm to initiate virus replication (Harrison, 2005,
2008; Weissenhorn et al., 2007). The glycoproteins of
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several bunyaviruses, such as LACV and BUNV (orthobu-
nyaviruses) (Jacoby et al., 1993; Plassmeyer et al., 2005; Shi
et al., 2007), RVFV (phlebovirus) (Filone et al., 2006),
HTNV (hantavirus) (Ogino et al., 2004) and tomato
spotted wilt tospovirus (TSWV) (Whitfield et al., 2005),
are reported to mediate acidic pH-dependent cell fusion.
Bioinformatic proteomic analyses suggested that the Gc
proteins of bunyaviruses share several sequence and
structure-motif similarities with envelope protein I of
Sindbis virus, a class II fusion protein (Garry & Garry,
2004). Recent data on LACV and hantavirus glycoproteins
support the notion that Gc functions as the fusion protein
(Plassmeyer et al., 2005, 2007; Tischler et al., 2005).
However, as mutations in the CT of BUNV Gn affect
membrane fusion severely (Shi et al., 2007), Gn must also
play an important role in the fusion process.
We constructed 12 glycoprotein precursor mutants that
contain progressive deletions in the N terminus-encoding
region of the BUNV Gc protein and investigated the role of
the Gc ectodomain in virus replication with regard to Golgi
targeting, fusogenicity, virus-like particle (VLP) formation
and virus infectivity. Our data reveal that the N-terminal
half of the Gc ectodomain is dispensable for intracellular
Golgi targeting and low pH-induced cell fusion.
METHODS
Cells and viruses. BHK-21 and BSR-T7/5 (Buchholz et al., 1999)
cells were maintained in Glasgow minimal essential medium
(Invitrogen) supplemented with 10% tryptose phosphate broth,
10% fetal calf serum and, for BSR-T7/5 cells only, 1 mg geneticin
ml21 (G418 sulfate; Calbiochem) as described previously (Lowen et
al., 2004; Shi & Elliott, 2004). Working stocks of wild-type (wt)
BUNV were grown in BHK-21 cells and titres were determined by
plaque assay as described previously (Watret et al., 1985).
Antibodies. A rabbit antiserum against purified BUNV virions (anti-
BUN) has been described previously (Lappin et al., 1994; Watret et al.,
1985). A mouse monoclonal antibody (mAb) against GM130, a cis-
Golgi matrix protein (Nakamura et al., 1995), was purchased from
BD Biosciences. Goat anti-rabbit antibody conjugated with fluor-
escein isothiocyanate was purchased from Sigma and goat anti-mouse
antibody conjugated with Cy5 was purchased from Chemicon
International, Inc.
Plasmids. Plasmids that express BUNV proteins (pTM1-BUNL for
expressing L protein, pTM1-BUNM for expressing Gn, NSm and Gc,
and pTM1-BUNS for expressing N) or generate full-length anti-
genome RNA transcripts [pT7riboBUNL(+), pT7riboBUNM(+)
and pT7riboBUNS(+)] have been described previously (Bridgen &
Elliott, 1996; Lowen et al., 2004), as has the BUNV-derived
minigenome, pT7riboBUNMRen(2) (which contains the Renilla
luciferase gene) (Weber et al., 2001). pTM1-FF-Luc contains the
firefly luciferase gene in the vector pTM1 (Weber et al., 2002). Twelve
BUNV M segment cDNA mutants that contain progressive deletions
in the N terminus-encoding region of the Gc protein were derived
from both pT7riboBUNM(+) and pTM1-BUNM by using a PCR
mutagenesis approach (Shi & Elliott, 2002) (Fig. 1). All constructs
were confirmed by DNA sequence analysis. The primers used and
details of PCR are available upon request.
Metabolic radiolabelling and immunoprecipitation. Procedures
for metabolic radiolabelling and immunoprecipitation of BUNV
proteins were described previously (Shi et al., 2004). Briefly, at 24 h
post-transfection or at various time points after virus infection (as
detailed in the figure legends), cells were labelled with [35S]methionine
(80 mCi/2.96 MBq) for 1 h and then lysed on ice with either 150 ml
(for direct SDS-PAGE analysis) or 300 ml (for immunoprecipitation)
non-denaturing RIPA buffer [50 mM Tris/HCl (pH 7.4), 1% Triton
X-100, 300 mM NaCl, 5 mM EDTA] containing a cocktail of protease
inhibitors (Roche). BUNV glycoproteins were immunoprecipitated
Fig. 1. BUNV glycoprotein Gc mutants. The
layout of the BUNV M segment-encoded gene
product is shown at the top, with positions of
amino acid residues marking protein bound-
aries (Gn, NSm and Gc) indicated. Below are
shown schematics of the proteins encoded by
wt and mutant (MD1, etc.) cDNA clones.
Deletions start at residue 480 to keep intact
the cleavage site between NSm and Gc. The
N-terminal position of each mutant Gc protein
and the number of residues (aa) deleted are
shown. The M segment gene products of
MAGV and its two non-ts revertant viruses R1
and R2 (Pollitt et al., 2006) are shown
beneath. Predicted transmembrane domains
(TMD) and the fusion peptide (FP) in BUNV
Gc (residues 1058–1079) are shown as grey
and hatched boxes, respectively. X indicate
glycosylation sites. Viruses recovered from
mutant M segment cDNAs by reverse genetics
are marked with an asterisk (*).
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with anti-BUN serum that had been conjugated to protein A–
Sepharose (Sigma). The beads were washed with RIPA buffer
containing 0.1% Triton X-100 and once with ice-cold PBS, and the
bound proteins were analysed by SDS-PAGE under reducing
conditions.
Indirect immunofluorescence staining. Immunofluorescence
assays were performed as described previously (Shi & Elliott, 2002).
Briefly, transfected cells were fixed with 4% paraformaldehyde and
then permeabilized with 0.1% Triton X-100 in PBS before staining
with specific primary antibodies and secondary antibody conjugates.
Localization of fluorescently labelled proteins was examined by using
a Zeiss LSM confocal microscope.
BUNV glycoprotein fusion assay. The fusion assay was performed
as described previously (Shi et al., 2007). Briefly, BSR-T7/5 cells
grown on 12-well plates were transfected with 1 mg of either pTM1-
BUNM or one of the mutant M cDNAs. At 24 h post-transfection,
cells were treated with low-pH medium (pH 5.3) for 5 min and then
the medium was replaced by normal growth medium. Cell fusion was
observed after further incubation for 4 h at 37 uC and Giemsa
staining. Fusion was quantified by counting the number of cells and
nuclei present in a microscopic field. Fusion index (f) was calculated
according to the equation f5[12(c/n)], where c is the number of cells
in a field and n the number of nuclei (White et al., 1981). An average
field at a magnification of6200 contained 400–600 nuclei. The mean
f from three fields was calculated.
Virus assembly assay. The assay to measure infectious VLP
production was performed as described previously with modifications
(Shi et al., 2006). Briefly, BSR-T7/5 cells grown in 12-well plates were
transfected with a plasmid mixture containing pTM1-BUNS
(0.05 mg), pTM1-BUNL (0.1 mg), pTM1-BUNM or one of the M
cDNA mutants cloned in pTM1 (0.1 mg) and 0.2 mg of the BUNV-
derived minigenome, pT7riboBUNMRen(2), together with 0.05 mg
pTM1-FF-luc as internal control. At 24 h post-transfection, the
supernatant was used to infect fresh BSR-T7/5 cells that had
previously been transfected with pTM1-BUNS (0.05 mg) and pTM1-
BUNL (0.1 mg). Renilla luciferase activity was measured after a further
24 h incubation by using a Dual-Luciferase Assay kit (Promega)
according to the manufacturer’s instructions.
Virus rescue by reverse genetics and virus growth curves.
Rescue experiments were performed as described previously (Lowen
et al., 2004). Briefly, BSR-T7/5 cells were transfected with a mixture of
three plasmids: 1.0 mg each of pT7riboBUNL(+), pT7riboBUNS(+)
and either pT7riboBUNM(+) or one of the mutant M cDNAs cloned
in pT7ribo. At 5 h post-transfection, 4 ml growth medium was added
and incubation was continued for 5–11 days at 33 uC. Transfectant
viruses were isolated by plaque formation on BHK-21 cells as
described previously (Watret et al., 1985). For virus growth curves,
BHK-21 cells in 35 mm diameter Petri dishes were infected at an
m.o.i. of 0.01 p.f.u. per cell and supernatants were harvested at
various times after infection. Virus titres were determined by plaque
formation on BHK-21 cells.
RESULTS
Generation and expression of mutant BUNV
glycoproteins containing deletions in the N
terminus of Gc
The complete BUNV Gc protein contains 957 residues,
comprising the ectodomain of 909 residues, a TM domain
of 23 residues and a relatively short CT of 25 residues
(Fig. 1). The TM domain was predicted by using the program
TMHMM (http://www.cbs.dtu.dk/services/TMHMM/; Moller
et al., 2001). To study the structure and function of the Gc
ectodomain in the virus life cycle, we generated 12 mutant
BUNV M segment cDNAs that contained truncations
ranging from 50 to 600 amino acid residues in the N
terminus-encoding region of Gc by PCR-directed mutagen-
esis (Fig. 1). To ensure that correct cleavage between Gc and
the upstream NSm protein in the precursor occurred at the
conserved Ala residue (A477; Elliott, 1990), the first three N-
terminal residues of Gc (A477, E478 and E479) were
retained in all deletion constructs. These three residues are
also maintained in the naturally occurring MAGV R1
mutant that has a large deletion at the N terminus of Gc
(Pollitt et al., 2006).
The mutant cDNA constructs were transfected into BSR-
T7/5 cells and the expressed proteins were analysed by
immunoprecipitation with anti-BUN antibodies and SDS-
PAGE (Fig. 2). Gc and Gn proteins were clearly identified
in cells transfected with the wt M segment cDNA (lane 2).
Progressive deletion of the N terminus of Gc resulted in
reduction in size of the Gc band in cells transfected with
mutants MD1–MD9. No Gc band could be identified
clearly in cells transfected with constructs MD10, MD11 or
MD12 (containing the largest deletions). However, Gn was
identified in all transfected cells, indicating that expression
and processing of the precursor protein did occur for all
constructs. This suggests that the failure to detect Gc for
mutants MD10–MD12 was probably due to loss of epitopes
recognizable by anti-BUN serum. It was noticeable that the
truncated Gc proteins expressed by MD1, MD2 and MD3
were obviously weaker than the Gc bands of wt M or the
other mutants, which may indicate a problem with efficient
expression or correct folding of these proteins.
Fig. 2. Proteins expressed from mutant BUNV M segment cDNAs.
BSR-T7/5 cells were transfected with cDNAs as indicated or left
untransfected (Mock) and labelled with [35S]methionine for 1 h at
24 h post-transfection, and cell lysates were reacted with anti-
BUN serum. Immunoprecipitated proteins were analysed on 4–
12% polyacrylamide NuPAGE gels (Invitrogen) under reducing
conditions. The positions of glycoproteins Gn and Gc and of
protein molecular mass markers (in kDa) are indicated.
Bunyamwera virus glycoproteins
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Intracellular localization of truncated BUNV
glycoproteins
Golgi trafficking and retention are characteristic of BUNV
glycoproteins and depend on proper folding of, and
heterodimer formation between, Gn and Gc. Maturation
and Golgi targeting of Gc are dependent on co-expressed
Gn that harbours the Golgi-targeting and -retention signal
in its TM domain (Lappin et al., 1994; Shi et al., 2004,
2005). To examine the effect of N-terminal deletions of Gc
on protein folding and intracellular trafficking, we
compared the intracellular location of the mutant proteins
by immunofluorescence, using a specific cis-Golgi matrix
marker, GM130 (Nakamura et al., 1995), in colocalization
studies. Unfortunately, none of the mutant Gc proteins
reacted with the available Gc-specific mAbs 742 and 810
(data not shown); these antibodies recognize an epitope
close to the first glycosylation site in Gc (residue N624; Shi
et al., 2005). Therefore, cells transfected with mutant
cDNAs were reacted with anti-BUN serum, which detects
both Gn and Gc glycoproteins. This hampered interpreta-
tion somewhat, as Gn by itself is able to target the Golgi,
albeit less efficiently than when co-expressed with func-
tional Gc (Lappin et al., 1994; Shi et al., 2004, 2005).
Of the 12 mutant BUNV M segment cDNA constructs,
the staining patterns of four mutants (MD1, MD7, MD8
and MD9) showed typical Golgi localization similar to
that of the wt BUNV M cDNA control, indicating that the
truncated Gc proteins expressed from these constructs
were able to target to the Golgi complex efficiently (Fig. 3,
compare panel 3 with panels 6, 24, 27 and 30). The
glycoproteins expressed by MD4 were predominantly
localized in the Golgi, although cytoplasmic staining was
also visible (panels 13–15). The glycoproteins expressed
by MD2, MD3, MD5 and MD6 showed mainly a
cytoplasmic staining pattern, suggesting that the muta-
tions in these constructs affected the protein folding and/
or interactions required for Golgi targeting. The glyco-
proteins expressed by MD10–MD12 showed rather weaker
staining, partially explainable by the reduced reactivity of
the truncated Gc proteins with anti-BUN serum. The
Golgi colocalization observable in cells transfected with
constructs MD3, MD5, MD6 and MD10–MD12 is, we
suggest, probably detection of Gn in this organelle. These
results showed that the impact of the deletions on the
ability of Gc to traffic to the Golgi was not linearly
proportional to the number of residues removed, but
probably reflected incorrect folding of the expressed
protein. For instance, Gc proteins expressed by MD2 and
MD3, with only 100 and 151 residues deleted respectively,
failed to transport to the Golgi, whereas Gc proteins
expressed by MD7, MD8 and MD9, with deletions of
between 347 and 450 residues, were still competent for
Golgi targeting and retention. Furthermore, our observa-
tions indicated that nearly half (49.5%) of the N-terminal
Gc ectodomain (as deleted in MD9) is not required for
Golgi trafficking.
Requirement of the Gc N terminus in low pH-
induced cell fusion
Low-pH treatment of either BUNV-infected or M cDNA-
transfected cells leads to cell fusion (Shi et al., 2007). To
investigate the involvement of the N terminus of Gc in cell
fusion, BSR-T7/5 cells transfected with the mutant cDNAs
were treated with low-pH medium (pH 5.3) and syncyt-
ium formation was quantified to estimate the fusion index.
As shown in Fig. 4(a), cell fusion was observed in cells
transfected with five mutant cDNAs (MD4 and MD6–
MD9). Large syncytia were seen in cells transfected with
MD4, MD7 and MD8, whereas smaller syncytia were
observed in cells transfected with MD6 and MD9 (marked
by arrows). No syncytium formation was seen in cells
transfected with the other seven constructs. Similar to the
effect on Golgi trafficking, the impact on cell-fusion
activity did not correlate with the number of amino acids
deleted. Deletions of 50, 100 and 151 residues (as in
constructs MD1–MD3, respectively) abrogated fusion
activity, whereas deletion of a further 67 residues
(construct MD4) restored the fusogenic activity of the
expressed glycoproteins. In fact, MD4, which has a deletion
of 218 residues at the N terminus of Gc, showed even
higher fusogenic activity (f50.894) than the wt control
(f50.623; Fig. 4b). Removal of an additional 34 residues
(construct MD5) again resulted in total loss of fusogenic
activity, but the successive deletion of residues 732–880
(constructs MD5–MD8) resulted in proteins that displayed
fusion activity to a level comparable to that of the wt
control (Fig. 4b). The cell fusion of construct MD9 was
reduced significantly (f50.181) and no syncytium forma-
tion was seen when deletions beyond residue 930 in the
central ectodomain, i.e. close to or including the predicted
fusion peptide, were made (constructs MD10–MD12) (Fig.
4a, b). Our data suggest that the N-terminal 401 residues
are not involved in the fusion process, whereas the central
region of the Gc ectodomain from residues 930 to 1080
(constructs MD9–MD12) is needed for fusion to occur.
Role of the Gc N terminus in virus particle
assembly and viability
The effect of N-terminal deletions on virus assembly was
assessed by the formation of infectious VLPs that package a
genome analogue encoding the Renilla luciferase gene (Shi et
al., 2006). As shown in Fig. 5(a), infectious VLPs were
produced in cells transfected with constructs MD4, MD7,
MD8 and MD9. However, VLP formation was reduced
significantly to approximately 1% of that of the wt control.
VLP formation was just detectable in cells transfected with
MD6 (a reflection of the sensitivity of the assay), whereas no
VLPs were made in cells transfected with the other
constructs. Consistent with the results above for the VLP-
formation assay, we were able to recover by reverse genetics
four viable recombinant viruses from Gc deletion constructs
MD4, MD7, MD8 and MD9 (the mutant viruses were
designated rBUNGcD4, rBUNGcD7, rBUNGcD8 and
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rBUNGcD9). Analysis of the protein profiles of cells infected
with the mutant viruses by SDS-PAGE showed that the
viruses expressed smaller Gc proteins corresponding to the
deletions introduced into the cDNA clones (Fig. 5b).
Effect of deletions in the N terminus of Gc on virus
replication
The availability of four mutant viruses enabled us to
investigate further the role of the N terminus in virus
replication by comparing plaque size, growth kinetics and
ability to shut off host protein synthesis. In BHK-21 cells,
the four mutant viruses made plaques smaller than those of
wt BUNV; in particular, rBUNGcD8 and rBUNGcD9
produced the smallest plaques (Fig. 6a). Virus growth
kinetics were compared in BHK-21 cells at two tempera-
tures following low-multiplicity infection (i.e. multi-step
growth cycle; Fig. 6b). Recombinant viruses rBUNGcD4,
rBUNGcD8 and rBUNGcD9 were attenuated, reaching
titres 10- to 100-fold lower than wt BUNV at 37 uC. The
Fig. 3. Intracellular localization of BUNV glycoproteins. BSR-T7/5 cells were transfected with wt or mutant BUNV M segment
cDNAs as indicated or left untransfected (C), and stained with a mixture of rabbit anti-BUN and mouse anti-GM130 antibodies.
BUNV glycoproteins Gn and Gc stain green and GM130 stains red. In merged images, the colocalization of BUNV glycoprotein
and GM130 shows as yellow. Nuclei were stained blue with 49,6-diamidino-2-phenylindole (DAPI).
Bunyamwera virus glycoproteins
http://vir.sgmjournals.org 2487
Fig. 4. Low pH-induced syncytium formation.
BSR-T7/5 cells were transfected with wt or
mutant BUNV M segment cDNA constructs or
left untransfected as a control (C). At 24 h
post-transfection, cells were treated with low-
pH medium (pH 5.3) for 5 min and syncytium
formation was examined following incubation
at 37 6C for a further 5 h. Cells were then
stained with Giemsa solution. (a) Syncytium
formation in cells transfected with wt (wt M)
and mutant BUN M segment cDNAs (MD1–
MD12) as indicated. The small syncytia formed
by cells transfected with MD6 and MD9
cDNAs are marked by white arrows. (b)
Fusion indices (f ), calculated as described in
Methods from cells treated with low-pH
medium.
Fig. 5. Effects of deletions in the N terminus of the Gc ectodomain on virus assembly. (a) VLP formation. BSR-T7/5 cells were
transfected with minigenome component plasmids together with either wt or mutant M segment cDNA constructs.
Supernatants from these cells were used to infect new BSR-T7/5 monolayers previously transfected with BUNV L and N
protein-expressing plasmids. Renilla luciferase activities were measured after a further 24 h incubation and are shown as
arbitrary light units. (b) Protein profiles of the rescued mutant viruses. BHK-21 cells were infected with either wt BUNV or
mutant viruses and cells were labelled with [35S]methionine for 1 h at 24 h post-infection. Cell lysates were analysed on 4–
12% polyacrylamide NuPAGE gels under reducing conditions. The positions of viral proteins are marked.
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differences were greater at 33 uC, with rBUNGcD9 showing
marked attenuation, growing 1000-fold less well than wt
BUNV. In contrast, rBUNGcD7, although growing more
slowly, reached almost similar titres to wt BUNV at both
temperatures by 48 or 60 h. The ability of the mutant
viruses to induce shut-off of host-cell protein synthesis in
BHK-21 cells reflected their slower growth rate compared
with wt BUNV when the cells were infected at an m.o.i. of
0.01 p.f.u. per cell: wt BUNV achieved almost complete
shut-off by 36 h post-infection, whereas the mutant viruses
showed only minimal host shut-off at 48 h post-infection.
Taken together, our data indicated that although all of the
mutant viruses were able to infect mammalian cells, they
were attenuated, suggesting that the Gc ectodomain is
indeed required for efficient replication in BHK-21 cells.
DISCUSSION
Infection of cells by enveloped viruses is initiated by the
release of the virus genome into the replication compart-
ment through the fusion of viral and cellular membranes, a
process that is mediated by the viral fusion protein(s)
(Harrison, 2008; Kielian & Rey, 2006; Weissenhorn et al.,
2007). Our results revealed that the N-terminal region of
the Gc ectodomain (up to residue 880) is not required for
Fig. 6. Plaque phenotypes, growth kinetics and protein synthesis profiles of wt and mutant viruses. (a) Comparison of plaque
size on BHK-21 cells. Monolayers were fixed 6 days post-infection with 4% formaldehyde and stained with Giemsa solution.
(b) Virus growth curves in BHK-21 cells (at 37 and 33 6C). Cells were infected with either wt (X) or recombinant
(h, rBUNGcD4; g, rBUNGcD7;#, rBUNGcD8; , rBUNGcD9) viruses at an m.o.i. of 0.01 p.f.u. per cell. Virus was harvested
at intervals as indicated and titrated by plaque formation in BHK-21 cells. Results are shown as the mean of two independent
titrations. (c) Time-course of protein synthesis in infected BHK-21 cells. Cells were infected at an m.o.i. of 0.01 p.f.u. per cell
and were labelled with 80 mCi [35S]methionine for 1 h at the time points indicated. Cell lysates were analysed on 4–12%
polyacrylamide NuPAGE gels. The positions of viral proteins are indicated; * indicates wt Gc.
Bunyamwera virus glycoproteins
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membrane fusion, in agreement with experimental data for
LACV Gc (Plassmeyer et al., 2005, 2007) and bioinformatic
predictions (Garry & Garry, 2004) suggesting that the
orthobunyavirus fusion peptide is located in the mem-
brane-proximal region. The fusion peptide of BUNV is
predicted to encompass residues 1058–1079 of Gc (Garry &
Garry, 2004) and is highly conserved among orthobunya-
viruses (Cortez et al., 2002). Indeed, mutagenesis of the
analogous region in an LACV Gc cDNA clone followed by
transient expression supported the notion that this domain
functions as the fusion peptide (Plassmeyer et al., 2007).
Our data indicate that the residues flanking the fusion
peptide are structurally critical for the conformational
change during the fusion process: deletion in the region
close to the fusion peptide (in constructs MD10–MD11) led
to abolition of cell fusion.
Membrane fusion mediated by the flavivirus E protein is
initiated by the protonation of specific histidine residues
near the fusion protein (Fritz et al., 2008). There are five
histidine residues conserved in orthobunyavirus Gc
ectodomains (at positions 797, 949, 1029, 1145 and 1295
in BUNV Gc), three of which are in the vicinity of the
predicted fusion peptide. The first consensus histidine
residue (H797) seems not to be involved in the fusion
process, as deletion of this residue did not affect cell fusion
(constructs MD7 and MD8). It would be of interest to
mutate the other histidine residues specifically to ascertain
their importance. It is usually the case that the N-terminal
region of a fusion protein (which often contains the
receptor-binding domain) must be displaced to allow
extension of the fusion peptide or fusion loop to target the
cellular membrane following the conformational change
(Harrison, 2008). With respect to BUNV Gc, removal of
the N-terminal 151 residues (construct MD4) actually
enhanced cell fusion, perhaps suggesting that deletion of
these residues facilitates the conformational change
required for cell fusion. Thus, the function of this region
could be to mask or protect the fusion peptide, although
further experimentation is required to investigate this
possibility.
Most enveloped viruses enter cells by receptor-mediated
endocytosis (Marsh & Helenius, 2006; Smith & Helenius,
2004). For orthobunyaviruses, the mechanism of how Gn
and Gc function in virus entry has still to be clarified
(Schmaljohn & Hooper, 2001). Ludwig et al. (1989, 1991)
suggested LACV Gc to be the attachment protein for
mammalian cells and Gn that for mosquito cells, whereas
others have described Gc as the attachment protein not
only for both mammalian and mosquito cells, but also for
mosquitoes (Hacker & Hardy, 1997; Hacker et al., 1995;
Pekosz et al., 1995; Plassmeyer et al., 2005; Sundin et al.,
1987). Our data presented above corroborate previous
results on MAGV (Pollitt et al., 2006) and indicate that the
N-terminal domain of Gc of viruses in the Bunyamwera
serogroup is not essential for infection of, and replication
in, cultured cells. However, the significant reduction in
VLP formation and attenuation of the mutant viruses
suggests that the N-terminal domain does play some role in
the infection process, and it would be informative to
investigate whether the mutants are impaired in their
ability to infect natural hosts. The fact that the mutant
virus rBUNGcD9, which lacks nearly half of the Gc
ectodomain, is still able to infect BHK cells suggests that
receptor-binding activity (either all or part) could reside in
the C-terminal half of Gc or that the Gn protein could also
act as a viral attachment protein, possibly via alternative
viral receptor(s). It is well-known that many viruses use
more than one type of receptor for their entry (Marsh &
Helenius, 2006).
Bunyavirus glycoproteins are targeted to, and retained in,
the Golgi complex, where viruses mature and bud. For
BUNV, correct protein folding and heterodimer formation
between Gn and Gc are prerequisites for Golgi trafficking
of both proteins, with Gn containing the Golgi-targeting
and -retention signal (Lappin et al., 1994; Shi et al., 2004,
2005, 2007). The efficient Golgi targeting of the mutant
glycoproteins expressed by constructs MD4, MD7, MD8
Fig. 7. Model of the domain structure of the BUNV Gc protein.
The lengths of BUNV glycoproteins Gn and Gc are drawn in
proportion to their actual sizes. The prediction of disordered
residues (a) and consensus secondary structure (b) of Gc,
obtained by using the Phyre server (Kelley & Sternberg, 2009),
are shown on the left. Disordered residues are indicated as shaded
boxes in (a), and a-helices and b-strands are shown as shaded
boxes and open arrows, respectively, in (b). The positions that
indicate the residues of the N and C termini of Gn and Gc within
the precursor protein, and residues defining the deletion mutations
(MD4, MD7–MD10 and MD12), are shown. The predicted fusion
peptide in Gc (residues 1058–1079) is indicated as a hatched
box.
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and MD9 indicated that the N-terminal half of the Gc
ectodomain (residues 477–929) is not required for proper
folding or heterodimeric interaction with Gn, which are
presumably undertaken by residues in the C-terminal half
of the Gc protein (residues 930–1433).
The analyses of the BUNV Gc ectodomain reported herein
allow us to suggest a functional domain structure of the
protein, in which the C-terminal half is essential for cell
fusion, with the boundary lying between residues 930 and
982 (constructs MD9 and MD10). Assays for Golgi
targeting, cell fusion and VLP formation are consistent
with the N-terminal ectodomain comprising at least two
structural domains (I and II; Fig. 7). Alignment of the
model with the consensus secondary structure predicted
by using the Phyre protein structure-ediction server
(Kelley & Sternberg, 2009) revealed that domain I is
mainly formed by a group of a-helices, whereas domain II
is composed of coils, b-strands and two short a-helices
(Fig. 7). Of note is that the regions linking domains I and
II, and domain II with the downstream domain, are
predicted to be disordered. Complete removal of either
domain I (in the case of construct MD4) or domains I
and II together (construct MD8) did not obviously affect
the functions of Golgi targeting, fusogenicity or virus
infectivity. However, deletions within domain I (con-
structs MD1–MD3) or within domain II (constructs MD5
and MD6) affected Gc function severely, suggesting that
the remaining sequence that results from partial deletions
within a domain would disrupt the overall structure, and
thus functions, of the Gc protein. However, as the N-
terminal region of Gc is dispensable for virus replication
in tissue culture, it might be possible to insert foreign
sequences, e.g. encoding an autofluorescent protein, in its
place to generate recombinant BUNV expressing a tagged
glycoprotein. Such a construct would be a valuable tool to
investigate virus entry and budding processes, as has been
achieved for other viruses (Brandenburg & Zhuang, 2007
and references therein).
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